Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac 18F-FDG PET study

Normalization of metabolic flux data during clamp studies in humans

(2020) Kasper W. ter Horst et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Myocardial Viability Testing by Positron Emission Tomography: Basic Concepts, Mini-Review of the Literature and Experience From a Tertiary PET Center

(2020) Simon Madsen et al.   SEMINARS IN NUCLEAR MEDICINE

Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target

(2019) Antonis S. Manolis et al.   HEART FAILURE REVIEWS

Glucose Metabolism Abnormalities in Heart Failure Patients

(2019) Fabio Marsico et al.   Heart Failure Clinics

Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction

(2019) Szu-Ying Tsai et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study

(2018) Miikka-Juhani Honka et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study

(2018) Annamaria Iorio et al.   EUROPEAN JOURNAL OF HEART FAILURE

Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study

(2018) Gretha Boersma et al.   HORMONE AND METABOLIC RESEARCH

Whole-Body Imaging of Tissue-specific Insulin Sensitivity and Body Composition by Using an Integrated PET/MR System: A Feasibility Study

(2018) Emil Johansson et al.   RADIOLOGY

Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

(2017) Ovidiu Chioncel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Insulin action and resistance in obesity and type 2 diabetes

(2017) Michael P Czech   NATURE MEDICINE

CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis

(2016) Ele Ferrannini et al.   DIABETES CARE

“Heart failure, whole-body insulin resistance and myocardial insulin resistance: An intriguing puzzle”

(2016) Paola Gargiulo et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism

(2016) Roni Nielsen et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism

(2015) Giuseppe Daniele et al.   DIABETES CARE

Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes

(2015) Tushar P. Patel et al.   HEART FAILURE REVIEWS

Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy

(2013) N Fillmore et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3–TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study

(2013) Devjit Tripathy et al.   DIABETOLOGIA

Targeting fatty acid and carbohydrate oxidation — A novel therapeutic intervention in the ischemic and failing heart

(2011) Jagdip S. Jaswal et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy

(2010) James A. Fallavollita et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes

(2009) R. A. DeFronzo et al.   DIABETES CARE